Physician profile
Bruce E Bodner
NPI 1720034911
$6,465.86
in general payments reported to CMS, 2019-2025
35 companies · $1,033 in 2025
The $1,033 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $1,223 · 2021: $2,028 · 2022: $377 · 2023: $1,289 · 2024: $125 · 2025: $1,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,350 · Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,350.00 |
| Food and Beverage | $1,097.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,446.95 | 2021-2023 | Dextile |
| Covidien LP | $998.82 | 2019-2020 | |
| Bolder Surgical, LLC | $675.00 | 2023 | Coolseal Generator |
| Atrium Medical Corporation | $675.00 | 2025 | Flixene |
| Smith+Nephew, INC. | $505.85 | 2019-2025 | Iodosorb Ointment 40g USA, Collagenase Santyl, Stravix |
| Gilead Sciences, INC. | $373.94 | 2021-2023 | Veklury |
| Abbvie INC. | $204.95 | 2021-2023 | Dalvance, Teflaro, Avycaz |
| Paratek Pharmaceuticals, INC. | $197.22 | 2020-2023 | Nuzyra |
| Mimedx Group, INC. | $142.70 | 2025 | |
| Tela Bio, INC. | $95.67 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $94.08 | 2019-2022 | |
| Medline Industries LP | $94.00 | 2024-2025 | Medline |
| Ethicon US, LLC | $88.31 | 2019-2022 | |
| Kerecis Limited | $87.98 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Merck Sharp & Dohme LLC | $76.61 | 2020-2024 | Dificid, Zerbaxa, Recarbrio |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $67.83 | 2023 | Symtuza |
| Astellas Pharma US INC | $59.46 | 2021 | |
| Kci USA, INC. | $58.05 | 2019 | |
| Convatec INC. | $57.49 | 2019-2021 | |
| La Jolla Pharmaceutical Company | $51.26 | 2021 | |
| Viiv Healthcare Company | $50.79 | 2020-2022 | |
| Tei Biosciences INC | $42.17 | 2019 | |
| Misonix INC | $38.86 | 2019-2021 | |
| Abbott Laboratories | $36.83 | 2020 | |
| W. L. Gore & Associates, INC. | $33.77 | 2019 | |
| Teleflex LLC | $32.66 | 2022 | |
| Organogenesis INC. | $31.09 | 2019 | |
| Lifenet Health | $23.51 | 2024 | Theragenesis Wound Matrix |
| Melinta Therapeutics, LLC | $20.21 | 2019 | |
| Acell, INC. | $19.95 | 2020 | |
| Polynovo North America LLC | $19.62 | 2024 | Novosorb Btm |
| Hartmann USA, INC. | $18.20 | 2023 | Zetuvit Plus |
| Tactile Systems Technology INC | $17.16 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.03 | 2021 | |
| Medtronic Vascular, INC. | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Bodner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.